Meridian Bioscience reported $36.7M in Current Liabilities for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Accelerate Diagnostics AXDX:US 7.51M 1.81M
Atrion ATRI:US 14.82M 2.15M
Becton, Dickinson and BDX:US $ 6626M 1123M
Bio Rad Laboratories BIO:US $ 649.92M 62.86M
Cerulean Pharma CERU:US $ 15.91M 9.9M
Cerus CERS:US $ 64.72M 1.1M
Genmark Diagnostics GNMK:US $ 44.13M 3.46M
Luminex LMNX:US $ 57.56M 29.9M
Myriad Genetics MYGN:US $ 203.2M 67.8M
Neogen NEOG:US $ 50.76M 2.84M
Orasure Technologies OSUR:US $ 54.17M 7.6M
Oxford Immunotec Global OXFD:US $ 11.8M 0.99M
Quidel QDEL:US $ 297.09M 87.82M
Rockwell Medical RMTI:US $ 21.76M 12.28M
Sientra SIEN:US $ 71.68M 0.41M
Staar Surgical STAA:US $ 46.8M 5M
Thermo Fisher Scientific TMO:US $ 7753M 828M
Trinity Biotech TRIB:US $ 105.62M 73.97M
Utah Medical Products UTMD:US $ 5.01M 448K